Others Products Targets
- Voltage-gated Sodium (NaV) Channel (30)
- Voltage-gated Potassium (KV) Channel (38)
- Voltage-gated Calcium Channel (CaV) (38)
- TRPV (30)
- NFKB and IKB (30)
- GABAB Receptor (28)
- Lipoxygenase (8)
- Leukotriene and Related Receptor (13)
- Bradykinin Receptor (12)
- Others (20)
- Glucocorticoid Receptor (9)
- Cytokine Receptor (4)
- Cyclooxygenase (24)
- IRAK (1)
- NK2 Receptor (7)
- NK1 Receptor (15)
- NOP Receptor (21)
- Mu-Opioid Receptors (15)
- Kappa Opioid Receptors (14)
- Glutamate (Metabotropic) Group III Receptor (26)
- Glutamate (Metabotropic) Group II Receptor (33)
- Glutamate (Metabotropic) Group I Receptor (54)
- AMPA Receptor (45)
- GABAA-ρ Receptor (8)
- GABAA Receptor (66)
- GPR55 (8)
- CB2 Receptor (6)
- CB1 Receptor (17)
- Nicotinic (α7) Receptor (25)
- Nicotinic (α4β2) Receptor (14)
- NK3 Receptor (5)
- NMDA Receptor (87)
- Kainate Receptor (22)
- CCK2 Receptor (7)
- CCK1 Receptor (3)
- NO donors and precursors (9)
- nNOS (5)
- iNOS (11)
- eNOS (1)
- Delta opioid receptor (16)
- Purinergic (P2X) Receptor (32)
- Prostanoid Receptor (24)
Products for Others - Page 51
- Cat.No. Product Name Information/Activity
-
BCC6052
UBP 310
902464-46-4
-
BCC5883
PDZ1 Domain inhibitor peptide
1315378-73-4
-
BCC7995
2-MPPA
254737-29-6
-
BCC6634
N-Acetylglycyl-D-glutamic acid
135701-69-8
-
BCC6612
L-AP6
78944-89-5
-
BCC7400
L-BMAA hydrochloride
16012-55-8
-
BCC6585
2,4-Dihydroxyphenylacetyl-L-asparagine
111872-98-1
-
BCC5051
Lamotrigine
Lamotrigine(BW430C) is a novel anticonvulsant drug for inhibition of 5-HT and sodium channel Target: Sodium Channel Lamotrigine stabilises presynaptic neuronal membranes by blockade of voltage-dependent sodium channels, thus preventing the release of excitatory neurotransmitters, particularly glutamate and aspartate [1].
-
BCC7086
MNI-caged-L-glutamate
295325-62-1
-
BCC6731
Salsolinol-1-carboxylic acid
57256-34-5
